Seaport Therapeutics, Inc. · NASDAQ:SPTX
Chen Michael Cunyuan converted 3,351 Seaport Therapeutics, Inc. shares (Form 4)
Traded May 4, 2026 · Filed May 4, 2026
On May 4, 2026, Chen Michael Cunyuan (Chief Scientific Officer) converted 3,351 Seaport Therapeutics, Inc. shares, leaving 3,351 shares. Filed May 4, 2026 (Form 4).
- Converted
- 3,351 shares
- Holding after
- 3,351 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Conversion | 3,351 | 3,351 | Direct |
Source
Related
- Seaport Therapeutics, Inc.
- Chen Michael Cunyuan
- Seaport Therapeutics, Inc. shareholders
- Schedule 13G · PureTech Health plc · Aug 14, 2026
- Schedule 13G · Paul Steven M · Aug 5, 2026
- Schedule 13G · Zohar Daphne · Aug 5, 2026
- Form 4 · Hombach Robert J. · Jun 24, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026